Drug-concentration versus symptom-driven dose adaptation of Infliximab in patients with active Crohn's disease: a prospective, randomised, multicentre trial (Tailorix)

D'Haens, G; Vermeire, S; Lambrecht, G; Baert, F; Bossuyt, P; Nachury, M; Buisson, A; Bouhnik, Y; Filippi, J; Vande Woude, J; Van Hootegem, P; Moreau, J; Louis, E; Franchimont, D; De Vos, M; Mana, F; Peyrin-Biroulet, L; Brixi, H; Allez, M; Caenepeel, P; Aubourg, A; Oldenburg, B; Pierik, M; Gils, A; Chevret, S; Laharie, D

Drug-concentration versus symptom-driven dose adaptation of Infliximab in patients with active Crohn's disease: a prospective, randomised, multicentre trial (Tailorix)

Author:

D'Haens, G

Vermeire, S ; Lambrecht, G ; Baert, F ; Bossuyt, P ; Nachury, M ; Buisson, A ; Bouhnik, Y ; Filippi, J ; Vande Woude, J ; Van Hootegem, P ; Moreau, J ; Louis, E ; Franchimont, D ; De Vos, M ; Mana, F ; Peyrin-Biroulet, L ; Brixi, H ; Allez, M ; Caenepeel, P ; Aubourg, A ; Oldenburg, B ; Pierik, M ; Gils, A ; Chevret, S ; Laharie, D

Keywords:

Science & Technology, Life Sciences & Biomedicine, Gastroenterology & Hepatology, 1103 Clinical Sciences, 3202 Clinical sciences